CDER New March 17, 2015

FDA (U.S. Food and Drug Administration)

What's New on the FDA Drugs Site

March 16, 2015

 


New and Generic Drug Approvals

March 13, 2015

Drug NameActive IngredientDosage Form/RouteSponsorSubmission Type
Depacon valproate sodium Injectable;Injection Abbvie Labeling Revision
Depakene valproic acid Syrup;Oral Abbvie Labeling Revision
Depakote divalproex sodium Tablet, Delayed Release;Oral Abbvie Labeling Revision
Depakote divalproex sodium Capsule, Delayed Rel Pellets;Oral Abbvie Labeling Revision
Depakote Er divalproex sodium Tablet, Extended Release;Oral Abbvie Labeling Revision
Humalog insulin lispro recombinant Injectable;Injection Lilly Labeling Revision
Humalog Kwikpen insulin lispro recombinant Injectable;Injection Lilly Labeling Revision
Humalog Pen insulin lispro recombinant Injectable;Injection Lilly Labeling Revision
Kepivance palifermin Injectable; Injection Biovitrum Ab Labeling Revision
Nexterone amiodarone hydrochloride Injectable;Injection Baxter Hlthcare Labeling Revision

 


This email was sent to rssproject471@gmail.com using GovDelivery, on behalf of: U.S. Food & Drug Administration (FDA) · 10903 New Hampshire Ave · Silver Spring, MD 20993 · 800-439-1420 Powered by GovDelivery

Postingan terkait:

Belum ada tanggapan untuk "CDER New March 17, 2015"

Post a Comment